|   | |
|   | |
| Clinical data | |
|---|---|
| Trade names | Aponeuron | 
| Other names | Amphetaminil; AN-1; N-Cyanobenzylamphetamine; N-(α′-Cyanobenzyl)amphetamine | 
| Routes of administration | Oral | 
| Drug class | Stimulant; Appetite suppressant; Norepinephrine–dopamine releasing agent | 
| ATC code | 
 | 
| Legal status | |
| Legal status | 
 | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.037.767 | 
| Chemical and physical data | |
| Formula | C17H18N2 | 
| Molar mass | 250.345 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
|   (what is this?)    (verify) | |
Amfetaminil (also known as amphetaminil, N-cyanobenzylamphetamine, [1] and AN-1; brand name Aponeuron) is a stimulant drug derived from amphetamine, which was developed in the 1970s and used for the treatment of obesity, [2] ADHD, [3] [4] and narcolepsy. [5] It has largely been withdrawn from clinical use following problems with abuse. [6] The drug is a prodrug to amphetamine. [7] [8]
Amfetaminil is a molecule with two stereogenic centers. Thus, four different stereoisomers exist:
 
 Schiff base formation between amphetamine (1) and benzaldehyde (2) gives benzalamphetamine [2980-02-1] (3). Nucleophilic attack of cyanide anion on the imine (c.f. Strecker reaction) gives amfetaminil (4). Finally, reaction with nitrous acid gives (5). The rearrangement to a Sydnone then occurs to give CID:88166659 (6). Feprosidnine is sans the phenyl group.